دورية أكاديمية
Corrigendum: Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer
| العنوان: | Corrigendum: Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer |
|---|---|
| المؤلفون: | Dalgleish, AG, Stebbing, J, Adamson, DJ, Arif, SS, Bidoli, P, Chang, D, Cheeseman, S, Diaz-Beveridge, R, Fernandez-Martos, C, Glynne-Jones, R, Granetto, C, Massuti, B, McAdam, K, McDermott, R, Martín, AJ, Papamichael, D, Pazo-Cid, R, Vieitez, JM, Zaniboni, A, Carroll, KJ, Wagle, S, Gaya, A, Mudan, SS |
| المساهمون: | Cancer Research UK |
| المصدر: | e16 |
| بيانات النشر: | Cancer Research UK |
| سنة النشر: | 2016 |
| المجموعة: | Imperial College London: Spiral |
| مصطلحات موضوعية: | Science & Technology, Life Sciences & Biomedicine, Oncology, 1112 Oncology And Carcinogenesis, Oncology & Carcinogenesis |
| جغرافية الموضوع: | England |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| تدمد: | 0007-0920 |
| العلاقة: | British Journal of Cancer; http://hdl.handle.net/10044/1/48907Test; https://dx.doi.org/10.1038/bjc.2016.342Test; 14549 |
| DOI: | 10.1038/bjc.2016.342 |
| الإتاحة: | https://doi.org/10.1038/bjc.2016.342Test http://hdl.handle.net/10044/1/48907Test |
| حقوق: | © 2016 Cancer Research UK. All rights reserved. Correction to: British Journal of Cancer (2016) 115, 789–796. doi:10.1038/bjc.2016.271. Original article at http://hdl.handle.net/10044/1/48908Test |
| رقم الانضمام: | edsbas.B8116675 |
| قاعدة البيانات: | BASE |
Full Text Finder | تدمد: | 00070920 |
|---|---|
| DOI: | 10.1038/bjc.2016.342 |